Skip to main content

Table 1 Demographic, clinical and microbiological data of 92 subjects

From: Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis

 

Septicemic melioidosis

Other sepsis

Recovery

Type 2 diabetes

Healthy

Training set (n = 34)

     

   Number of subjects

11

13

5

5

 

   Mean age in years (range)

54 (41-70)

56 (37-74)

46 (41-64)

40 (39-68)

 

   Sex (male/female)

7/4

4/9

3/2

1/4

 

   Survivors/non-survivors

6/5

11/2

   

   Organisms (n)

B. pseudomallei (11)

A. baumannii (1)

   
  

Corynebacterium spp. (2)

   
  

C. albicans (3)

   
  

E. coli (3)

   
  

Salmonella serotype B (1)

   
  

S. aureus (1)

   
  

Salmonella spp. (1)

   
  

Non-group A or B Streptococcus (1)

   

Independent test set 1 (n = 33)

     

   Number of subjects

13

11

4

2

3

   Mean age in years (range)

50 (18-70)

56 (37-70)

50 (39-64)

49 (48-50)

38 (35-43)

   Sex (male/female)

11/2

6/5

3/1

0/2

0/3

   Survivors/non-survivors

12/1

6/5

   

   Organisms (n)

B. pseudomallei (13)

Coagulase-negative staphylococci (6)*

   
  

E. coli (1)

   
  

Enterococcus spp. (1)

   
  

S. aureus (1)

   
  

K. pneumoniae (1)

   
  

S. pneumoniae (1)

   

Independent test set 2 (n = 25)

     

   Number of subjects

8

7

 

5

5

   Mean age in years (range)

47 (40-56)

61 (43-81)

 

57 (50-71)

44 (37-67)

   Sex (male/female)

4/4

2/5

 

0/5

3/2

   Survivors/non-survivors

3/5

5/2

 

5/0

5/0

   Organisms (n)

B. pseudomallei (8)

A. hydrophila (1)†

   
  

Corynebacterium spp. (1)

   
  

E. coli (2)†

   
  

S. aureus (1)

   
  

Enterococcus spp. (1)

   
  

E. faecium (1)

   
  1. *Three in six patients were positive in two sets of blood cultures. †Patients were positive in two sets of blood cultures.
Back to article page

Genome Biology

ISSN: 1474-760X

Contact us